## XPEV: XPeng Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 2.0% below STRENGTH zone (4.0-10.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($18.17)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 13.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 5 |

**Top Holders:**
- Alibaba Group Holdin: 4.3% (0.0%)
- TMT General Partner : 3.2% (-0.4%)
- Primecap Management : 1.8% (-3.7%)
- UBS Group AG: 1.3% (+23.8%)
- Marshall Wace LLP: 0.7% (+244.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.36 indicates undervaluation relative to growth. Revenue growth strong at 42% YoY. Institutional flow bullish (3 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.2B |
| Beta | 1.13 |
| 52W Range | $11.61 - $28.23 |
| Short Interest | 4.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.36 |
| Forward P/E | 7.7 |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_20 deteriorating from 4.3% to 2.0% (-2.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.0pp (needs >4.0% for momentum thesis). MRS_5 (-2.1%) diverging from MRS_20 - short-term weakness emerging. Below SMA200 (0.98x), long-term trend not supportive. RSI neutral at 49. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.02% (CS: 63) | Neutral |
| RSI_14 | 48.7 | Neutral |
| MACD Histogram | 0.24 | Bullish |
| vs SMA20 | 1.021x | Above |
| vs SMA50 | 0.939x | Below |
| vs SMA200 | 0.984x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $20.13
- **Stop Loss:** $18.17 (9.7% risk)
- **Target:** $22.09 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 586
- **Position Value:** $11,796.18
- **Portfolio %:** 11.80%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-03-17 (Est: $0.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.47 | $-0.16 | +65.8% |
| 2025Q2 | $-1.06 | $-0.41 | +61.4% |
| 2025Q1 | $-1.51 | $-0.45 | +70.2% |
| 2024Q4 | $-1.45 | $-1.47 | -1.6% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*